The global Human Growth Hormone (HGH) Drugs Market is expected to reach USD 9.49 Billion by 2032, growing at a CAGR of 7% during the forecast period, from a value of USD 5.16 Billion in 2022. The increasing prevalence of genetic abnormalities, brain traumas, and an aging population, as well as radiation therapy and rising public awareness of the benefits of HGH therapy, are driving...